AstraZeneca

About

AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.

Cambridge,Cambridgeshire,United Kingdom
10001 - max
http://www.astrazeneca.com

Highlights

Details

Last Funding Type: IPO
Industries: Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical
Founded date: Apr 6, 1999
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: nse:ASTRAZEN
Legal Name: AstraZeneca PLC

AstraZeneca is global innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.

AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

AstraZeneca has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 4, 2001 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 4, 2001	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

41

14

AstraZeneca has made 41 investments. Their most recent investment was on Dec 8, 2022, when GenAssist Therapeutics raised 0.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 8, 2022 GenAssist Therapeutics	Series A	—	Biotechnology	Yes
Nov 29, 2022 Rgenta Therapeutics	Series A	$52M	Biotechnology	Yes
Nov 28, 2022 ZSHK Laboratories	Series B	¥90M		Yes
Aug 19, 2022 Yunjian	Series B	—	Biotechnology	Yes
Aug 1, 2022 Doctor.One	Grant	€85K	Health Care	Yes

Employee Profiles

Number of Employee Profiles

142

AstraZeneca has 142 current employee profiles, including Executive Pascal Soriot

Executive

Board member

Advisor

Executive

Employee

Exits

AstraZeneca has had 9 exits. AstraZeneca most notable exits include Rani Therapeutics , ADC Therapeutics

Date	Company Name	Exit Type	Industry
Jul 30, 2021	Rani Therapeutics	IPO	Biotechnology	Detail
May 14, 2020	ADC Therapeutics	IPO	Biopharma	Detail
Oct 17, 2019	Innate Pharma	IPO	Biopharma	Detail
Oct 2, 2019	Viela Bio	M&A	Biopharma	Detail
Dec 6, 2018	Moderna Therapeutics	IPO	Biotechnology	Detail

Acquisition

AstraZeneca has acquired 16 organizations. Their most recent acquisition was KuDOS Pharmaceuticals Ltd on Dec 23, 2005. They acquired KuDOS Pharmaceuticals Ltd for $210M.

Date Company Name	Industry	Acquisition Type	Price
Dec 23, 2005 KuDOS Pharmaceuticals Ltd	Biotechnology	acquisition	$ 210M	Detail
May 18, 2006 Cambridge Antibody Technology	Biotechnology	acquisition	$ 567M	Detail
Feb 1, 2007 Arrow Therapeutics	Biotechnology	acquisition	$ 150M	Detail
Dec 23, 2009 Novexel	Biotechnology	—	—	Detail
Dec 8, 2011 Guangdong BeiKang Pharmaceutical Company Ltd	Manufacturing	acquisition	—	Detail